Cancer Conversations™: Experts Discuss and Debate Optimal Treatment of Relapsed/Refractory Multiple Myeloma

Download All
Engage with an on-demand recording of a live Webinar on R/R MM featuring a faculty moderator interviewing 2 expert faculty about key areas of consensus and controversy. Download the slides, read a related expert commentary, and listen to a podcast from the Webinar.
Shaji K. Kumar, MD
Program Director
Suzanne Lentzsch, MD, PhD
Saad Z. Usmani, MD, MBA, FACP

On-Demand Webcast

Watch this on-demand webcast from a live webinar where experts discussed and debated the latest data for the management of patients with relapsed or refractory myeloma.

Shaji K. Kumar, MD
Program Director
Suzanne Lentzsch, MD, PhD Saad Z. Usmani, MD, MBA, FACP
Physicians: maximum of 0.75 AMA PRA Category 1 Credits Released: March 31, 2021 Expired: March 30, 2022
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Bristol-Myers Squibb
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Oncopeptides

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue